Jump to page content


The Berlin Institute of Health (BIH), together with the Charité - Universitätsmedizin Berlin, has set up an interdisciplinary study program consisting of a series of basic and clinical studies, which aim to expand knowledge about the new coronavirus and its health consequences as well as therapy options as quickly as possible. Using state-of-the-art methods - such as mass spectrometry, single-cell sequencing and high-throughput immunocharacterization - for example, the researchers are investigating the changes SARS-CoV-2 causes in the body. The research projects also shed light on the role of the heart and immune system in the disease process. The studies also focus on possible secondary damage and its prevention. Last but not least, a number of therapy options are being examined.

Professor Axel R. Pries, former interim Chairman of the BIH Executive Board and Dean of Charité - Universitätsmedizin: “In light of the global threat posed by the SARS-CoV-2 virus, we as researchers have a duty to marshal all of our scientific knowledge to understand the virus and its infection strategies as well as the disease progression of COVID-19 patients. Only so can we better identify high-risk patients and develop new therapies and vaccines. Every contribution towards this effort makes a difference.”

In order to best promote research into SARS-CoV-2 and COVID-19 at the Charité and the BIH, the newly established Charité/BIH COVID-19 Research Board coordinates all research projects. Staffed by experts from a wide range of disciplines, it aims to promote synergies, make the use of scarce biomaterials as efficient as possible, and enable joint access to technologies. 

Here we will keep you informed about current developments regarding SARS-CoV-2 / COVID-19 and activities of the Berlin Institute of Health

Robert Koch Institute (RKI)

Up-to-date information on the novel coronavirus (e.g. symptoms, risk of infection, preventive measures) can be found on the website of the Robert Koch Institut.

Coronavirus update with BIH professor Christian Drosten on NDR

Prof. Christian Drosten, Director of the Institute of Virology at the Charité, gives a daily update on the coronavirus in the NDR Podcast.

Educational Ressources in the Corona Break

Make the best out of the Corona break and find helpful tools and courses for your research, compiled by QUEST Center. The Center also provides a continuously updated overview of resources on COVID-19 and Patient & Stakeholder Engagement.

Time for 3R

For the Corona period, Charité 3R has compiled tips on how to improve your research projects by 3R-related online resources.

Podcast-Folge 29

Wie funktionieren die Impfstoffe gegen SARS-CoV-2?

Worin unterscheidet sich ein mRNA Impfstoff von einem Vektorimpfstoff? Was sind Adenoviren in Vektorimpfstoffen? Wie funktionieren diese Impfstoffe? Wie entsteht eine Immunantwort gegen das neuartige Virus und wie lange hält der Impfschutz an? Und was ist eigentlich mit den Kindern? In unserem BIH Podcast sprechen wir mit Professor Leif Erik…

Listen to podcast


Sex, Gender

  • Sex, Gender and COVID-19

    During the current COVID-19 pandemic there is an urgent need to better understand sex/gender differences in predictors, trajectories and impacts of COVID-19 prevention and treatment. Data from differe

    Read more